Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer

BACKGROUND: There is a high unmet need for effective treatments for patients with squamous non-small cell lung cancer (NSCLC). Eli Lilly and Company is conducting a phase III, randomized, multicenter, open-label study of gemcitabine plus cisplatin plus necitumumab (GC + N) versus gemcitabine plus ci...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: DeLozier, Amy M, Brown, Jacqueline, Natanegara, Fanni, Zhao, Luping, Cui, Zhanglin Lin, Able, Stephen L, Bowman, Lee, Treat, Joseph, Hess, Lisa M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169645/
https://ncbi.nlm.nih.gov/pubmed/25227571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-102
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller